nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—CACNA1B—telencephalon—malignant glioma	0.017	0.0654	CbGeAlD
Gabapentin—BCAT1—retina—malignant glioma	0.0145	0.0559	CbGeAlD
Gabapentin—CACNA1B—Synaptic Vesicle Pathway—SYP—malignant glioma	0.0134	0.121	CbGpPWpGaD
Gabapentin—CACNA1B—medulla oblongata—malignant glioma	0.0133	0.0514	CbGeAlD
Gabapentin—CACNA2D2—telencephalon—malignant glioma	0.0122	0.0472	CbGeAlD
Gabapentin—CACNA1B—midbrain—malignant glioma	0.0122	0.047	CbGeAlD
Gabapentin—CACNA1B—spinal cord—malignant glioma	0.0119	0.0459	CbGeAlD
Gabapentin—BCAT1—medulla oblongata—malignant glioma	0.0105	0.0404	CbGeAlD
Gabapentin—CACNA2D1—brainstem—malignant glioma	0.00992	0.0382	CbGeAlD
Gabapentin—CACNA1B—central nervous system—malignant glioma	0.00965	0.0372	CbGeAlD
Gabapentin—BCAT1—midbrain—malignant glioma	0.00959	0.037	CbGeAlD
Gabapentin—CACNA1B—cerebellum—malignant glioma	0.00943	0.0364	CbGeAlD
Gabapentin—BCAT1—spinal cord—malignant glioma	0.00935	0.0361	CbGeAlD
Gabapentin—CACNA2D2—midbrain—malignant glioma	0.00879	0.0339	CbGeAlD
Gabapentin—CACNA2D2—spinal cord—malignant glioma	0.00858	0.0331	CbGeAlD
Gabapentin—ADORA1—telencephalon—malignant glioma	0.00849	0.0327	CbGeAlD
Gabapentin—CACNA1B—brain—malignant glioma	0.00766	0.0295	CbGeAlD
Gabapentin—BCAT1—central nervous system—malignant glioma	0.00759	0.0293	CbGeAlD
Gabapentin—BCAT1—cerebellum—malignant glioma	0.00742	0.0286	CbGeAlD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—BMI1—malignant glioma	0.00713	0.0646	CbGpPWpGaD
Gabapentin—CACNA2D2—central nervous system—malignant glioma	0.00696	0.0268	CbGeAlD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—PIM1—malignant glioma	0.00695	0.0629	CbGpPWpGaD
Gabapentin—CACNA2D2—cerebellum—malignant glioma	0.0068	0.0262	CbGeAlD
Gabapentin—ADORA1—medulla oblongata—malignant glioma	0.00667	0.0257	CbGeAlD
Gabapentin—ADORA1—midbrain—malignant glioma	0.0061	0.0235	CbGeAlD
Gabapentin—BCAT1—brain—malignant glioma	0.00602	0.0232	CbGeAlD
Gabapentin—ADORA1—spinal cord—malignant glioma	0.00595	0.0229	CbGeAlD
Gabapentin—CACNA2D2—brain—malignant glioma	0.00552	0.0213	CbGeAlD
Gabapentin—Myasthenia—Carmustine—malignant glioma	0.00528	0.00838	CcSEcCtD
Gabapentin—Oral candidiasis—Carmustine—malignant glioma	0.00522	0.00829	CcSEcCtD
Gabapentin—Encephalopathy—Carmustine—malignant glioma	0.00517	0.0082	CcSEcCtD
Gabapentin—Aphasia—Carmustine—malignant glioma	0.00512	0.00812	CcSEcCtD
Gabapentin—Oral candidiasis—Temozolomide—malignant glioma	0.00505	0.00801	CcSEcCtD
Gabapentin—CACNA2D1—central nervous system—malignant glioma	0.00501	0.0193	CbGeAlD
Gabapentin—Tooth disorder—Temozolomide—malignant glioma	0.00494	0.00785	CcSEcCtD
Gabapentin—Aphasia—Temozolomide—malignant glioma	0.00494	0.00785	CcSEcCtD
Gabapentin—Hypokinesia—Carmustine—malignant glioma	0.00492	0.0078	CcSEcCtD
Gabapentin—CACNA2D1—cerebellum—malignant glioma	0.00489	0.0189	CbGeAlD
Gabapentin—Paranoia—Carmustine—malignant glioma	0.00487	0.00773	CcSEcCtD
Gabapentin—ADORA1—central nervous system—malignant glioma	0.00483	0.0186	CbGeAlD
Gabapentin—ADORA1—cerebellum—malignant glioma	0.00472	0.0182	CbGeAlD
Gabapentin—Lung disorder—Temozolomide—malignant glioma	0.00453	0.00719	CcSEcCtD
Gabapentin—Apathy—Temozolomide—malignant glioma	0.00449	0.00712	CcSEcCtD
Gabapentin—Flat affect—Temozolomide—malignant glioma	0.00445	0.00706	CcSEcCtD
Gabapentin—Stupor—Carmustine—malignant glioma	0.00444	0.00705	CcSEcCtD
Gabapentin—Scotoma—Carmustine—malignant glioma	0.00437	0.00693	CcSEcCtD
Gabapentin—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00433	0.00688	CcSEcCtD
Gabapentin—Menorrhagia—Temozolomide—malignant glioma	0.00433	0.00688	CcSEcCtD
Gabapentin—Herpes zoster—Temozolomide—malignant glioma	0.00426	0.00676	CcSEcCtD
Gabapentin—Scotoma—Temozolomide—malignant glioma	0.00422	0.0067	CcSEcCtD
Gabapentin—Abscess—Carmustine—malignant glioma	0.00419	0.00666	CcSEcCtD
Gabapentin—Otitis media—Temozolomide—malignant glioma	0.00412	0.00654	CcSEcCtD
Gabapentin—Coagulopathy—Temozolomide—malignant glioma	0.00412	0.00654	CcSEcCtD
Gabapentin—Hyperaesthesia—Temozolomide—malignant glioma	0.00409	0.00648	CcSEcCtD
Gabapentin—Memory impairment—Temozolomide—malignant glioma	0.00409	0.00648	CcSEcCtD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—ATP1B2—malignant glioma	0.00404	0.0365	CbGpPWpGaD
Gabapentin—CACNA2D1—brain—malignant glioma	0.00397	0.0153	CbGeAlD
Gabapentin—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.0039	0.00619	CcSEcCtD
Gabapentin—BCAT1—Amino acid and derivative metabolism—ASMT—malignant glioma	0.0039	0.0353	CbGpPWpGaD
Gabapentin—Speech disorder—Carmustine—malignant glioma	0.00386	0.00612	CcSEcCtD
Gabapentin—ADORA1—brain—malignant glioma	0.00383	0.0148	CbGeAlD
Gabapentin—Accidental injury—Carmustine—malignant glioma	0.00375	0.00595	CcSEcCtD
Gabapentin—Speech disorder—Temozolomide—malignant glioma	0.00373	0.00592	CcSEcCtD
Gabapentin—Breast pain—Temozolomide—malignant glioma	0.00368	0.00583	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TFRC—malignant glioma	0.00365	0.033	CbGpPWpGaD
Gabapentin—Amenorrhoea—Temozolomide—malignant glioma	0.00365	0.00579	CcSEcCtD
Gabapentin—Thinking abnormal—Carmustine—malignant glioma	0.00362	0.00575	CcSEcCtD
Gabapentin—Drug interaction—Carmustine—malignant glioma	0.00358	0.00568	CcSEcCtD
Gabapentin—Viral infection—Temozolomide—malignant glioma	0.00355	0.00563	CcSEcCtD
Gabapentin—Herpes simplex—Temozolomide—malignant glioma	0.00348	0.00552	CcSEcCtD
Gabapentin—Gait disturbance—Carmustine—malignant glioma	0.0034	0.0054	CcSEcCtD
Gabapentin—Coordination abnormal—Carmustine—malignant glioma	0.00338	0.00536	CcSEcCtD
Gabapentin—Hearing impaired—Temozolomide—malignant glioma	0.00337	0.00535	CcSEcCtD
Gabapentin—Neck pain—Carmustine—malignant glioma	0.00336	0.00533	CcSEcCtD
Gabapentin—Pulmonary embolism—Carmustine—malignant glioma	0.00332	0.00527	CcSEcCtD
Gabapentin—Gait disturbance—Temozolomide—malignant glioma	0.00329	0.00521	CcSEcCtD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—malignant glioma	0.00328	0.0297	CbGpPWpGaD
Gabapentin—Respiratory failure—Temozolomide—malignant glioma	0.00327	0.00518	CcSEcCtD
Gabapentin—Coordination abnormal—Temozolomide—malignant glioma	0.00327	0.00518	CcSEcCtD
Gabapentin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00321	0.00509	CcSEcCtD
Gabapentin—Pulmonary embolism—Temozolomide—malignant glioma	0.00321	0.00509	CcSEcCtD
Gabapentin—Depressed level of consciousness—Carmustine—malignant glioma	0.0032	0.00508	CcSEcCtD
Gabapentin—Urinary incontinence—Carmustine—malignant glioma	0.0032	0.00508	CcSEcCtD
Gabapentin—Skin exfoliation—Carmustine—malignant glioma	0.00317	0.00503	CcSEcCtD
Gabapentin—Candida infection—Carmustine—malignant glioma	0.00317	0.00503	CcSEcCtD
Gabapentin—Neuropathy—Carmustine—malignant glioma	0.00312	0.00494	CcSEcCtD
Gabapentin—Depressed level of consciousness—Temozolomide—malignant glioma	0.0031	0.00491	CcSEcCtD
Gabapentin—Urinary incontinence—Temozolomide—malignant glioma	0.0031	0.00491	CcSEcCtD
Gabapentin—Candida infection—Temozolomide—malignant glioma	0.00306	0.00486	CcSEcCtD
Gabapentin—Skin exfoliation—Temozolomide—malignant glioma	0.00306	0.00486	CcSEcCtD
Gabapentin—Neuropathy—Temozolomide—malignant glioma	0.00301	0.00478	CcSEcCtD
Gabapentin—Gynaecomastia—Carmustine—malignant glioma	0.00297	0.00471	CcSEcCtD
Gabapentin—Dry eye—Temozolomide—malignant glioma	0.00296	0.0047	CcSEcCtD
Gabapentin—Abnormal vision—Carmustine—malignant glioma	0.00289	0.00459	CcSEcCtD
Gabapentin—Sepsis—Carmustine—malignant glioma	0.00288	0.00457	CcSEcCtD
Gabapentin—Mental disability—Carmustine—malignant glioma	0.00288	0.00457	CcSEcCtD
Gabapentin—Abnormal vision—Temozolomide—malignant glioma	0.0028	0.00444	CcSEcCtD
Gabapentin—Phlebitis—Carmustine—malignant glioma	0.0028	0.00444	CcSEcCtD
Gabapentin—Mental disability—Temozolomide—malignant glioma	0.00278	0.00442	CcSEcCtD
Gabapentin—Thrombophlebitis—Carmustine—malignant glioma	0.00278	0.00442	CcSEcCtD
Gabapentin—Diabetes mellitus—Carmustine—malignant glioma	0.00277	0.00439	CcSEcCtD
Gabapentin—Swelling—Carmustine—malignant glioma	0.00273	0.00433	CcSEcCtD
Gabapentin—Ear pain—Temozolomide—malignant glioma	0.00273	0.00433	CcSEcCtD
Gabapentin—Thrombophlebitis—Temozolomide—malignant glioma	0.00269	0.00427	CcSEcCtD
Gabapentin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00268	0.00425	CcSEcCtD
Gabapentin—Eye pain—Carmustine—malignant glioma	0.00267	0.00423	CcSEcCtD
Gabapentin—Gastroenteritis—Temozolomide—malignant glioma	0.00263	0.00417	CcSEcCtD
Gabapentin—Injury—Carmustine—malignant glioma	0.00262	0.00416	CcSEcCtD
Gabapentin—Vascular purpura—Temozolomide—malignant glioma	0.0026	0.00413	CcSEcCtD
Gabapentin—Deafness—Temozolomide—malignant glioma	0.0026	0.00413	CcSEcCtD
Gabapentin—Hepatic failure—Temozolomide—malignant glioma	0.00259	0.00411	CcSEcCtD
Gabapentin—Eye pain—Temozolomide—malignant glioma	0.00258	0.00409	CcSEcCtD
Gabapentin—Amnesia—Carmustine—malignant glioma	0.00256	0.00407	CcSEcCtD
Gabapentin—Amnesia—Temozolomide—malignant glioma	0.00248	0.00393	CcSEcCtD
Gabapentin—Thirst—Temozolomide—malignant glioma	0.00245	0.00388	CcSEcCtD
Gabapentin—Hyponatraemia—Carmustine—malignant glioma	0.00242	0.00384	CcSEcCtD
Gabapentin—Purpura—Temozolomide—malignant glioma	0.00241	0.00383	CcSEcCtD
Gabapentin—Diplopia—Carmustine—malignant glioma	0.00241	0.00382	CcSEcCtD
Gabapentin—Diplopia—Temozolomide—malignant glioma	0.00233	0.00369	CcSEcCtD
Gabapentin—Face oedema—Carmustine—malignant glioma	0.00233	0.00369	CcSEcCtD
Gabapentin—Affect lability—Temozolomide—malignant glioma	0.00229	0.00364	CcSEcCtD
Gabapentin—Ataxia—Carmustine—malignant glioma	0.00226	0.00359	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—BIRC5—malignant glioma	0.00226	0.0204	CbGpPWpGaD
Gabapentin—Face oedema—Temozolomide—malignant glioma	0.00225	0.00357	CcSEcCtD
Gabapentin—Liver function test abnormal—Carmustine—malignant glioma	0.00222	0.00353	CcSEcCtD
Gabapentin—Mood swings—Temozolomide—malignant glioma	0.00221	0.0035	CcSEcCtD
Gabapentin—Ataxia—Temozolomide—malignant glioma	0.00219	0.00347	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TERT—malignant glioma	0.00219	0.0198	CbGpPWpGaD
Gabapentin—Dehydration—Temozolomide—malignant glioma	0.00216	0.00344	CcSEcCtD
Gabapentin—Dry skin—Temozolomide—malignant glioma	0.00213	0.00339	CcSEcCtD
Gabapentin—Muscular weakness—Carmustine—malignant glioma	0.00212	0.00337	CcSEcCtD
Gabapentin—Breast disorder—Temozolomide—malignant glioma	0.0021	0.00334	CcSEcCtD
Gabapentin—Dysphagia—Carmustine—malignant glioma	0.00208	0.0033	CcSEcCtD
Gabapentin—Muscular weakness—Temozolomide—malignant glioma	0.00205	0.00326	CcSEcCtD
Gabapentin—Dysphagia—Temozolomide—malignant glioma	0.00201	0.00319	CcSEcCtD
Gabapentin—Sweating increased—Temozolomide—malignant glioma	0.00196	0.00311	CcSEcCtD
Gabapentin—Bronchitis—Temozolomide—malignant glioma	0.00193	0.00307	CcSEcCtD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—YWHAE—malignant glioma	0.00192	0.0174	CbGpPWpGaD
Gabapentin—Dysuria—Temozolomide—malignant glioma	0.00188	0.00299	CcSEcCtD
Gabapentin—Hyperglycaemia—Carmustine—malignant glioma	0.00188	0.00298	CcSEcCtD
Gabapentin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00187	0.00297	CcSEcCtD
Gabapentin—Pneumonia—Carmustine—malignant glioma	0.00187	0.00296	CcSEcCtD
Gabapentin—Pollakiuria—Temozolomide—malignant glioma	0.00186	0.00295	CcSEcCtD
Gabapentin—Erectile dysfunction—Temozolomide—malignant glioma	0.00185	0.00294	CcSEcCtD
Gabapentin—Depression—Carmustine—malignant glioma	0.00185	0.00294	CcSEcCtD
Gabapentin—Photosensitivity reaction—Temozolomide—malignant glioma	0.00184	0.00291	CcSEcCtD
Gabapentin—Weight increased—Temozolomide—malignant glioma	0.00183	0.00291	CcSEcCtD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—malignant glioma	0.00183	0.0165	CbGpPWpGaD
Gabapentin—Renal failure—Carmustine—malignant glioma	0.00182	0.0029	CcSEcCtD
Gabapentin—Weight decreased—Temozolomide—malignant glioma	0.00182	0.00289	CcSEcCtD
Gabapentin—Neuropathy peripheral—Carmustine—malignant glioma	0.00182	0.00289	CcSEcCtD
Gabapentin—Hyperglycaemia—Temozolomide—malignant glioma	0.00181	0.00288	CcSEcCtD
Gabapentin—Stomatitis—Carmustine—malignant glioma	0.00181	0.00287	CcSEcCtD
Gabapentin—Urinary tract infection—Carmustine—malignant glioma	0.0018	0.00286	CcSEcCtD
Gabapentin—Pneumonia—Temozolomide—malignant glioma	0.0018	0.00286	CcSEcCtD
Gabapentin—Infestation—Temozolomide—malignant glioma	0.00179	0.00285	CcSEcCtD
Gabapentin—Infestation NOS—Temozolomide—malignant glioma	0.00179	0.00285	CcSEcCtD
Gabapentin—Depression—Temozolomide—malignant glioma	0.00179	0.00284	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00178	0.00282	CcSEcCtD
Gabapentin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00176	0.00279	CcSEcCtD
Gabapentin—Stomatitis—Temozolomide—malignant glioma	0.00175	0.00277	CcSEcCtD
Gabapentin—Urinary tract infection—Temozolomide—malignant glioma	0.00174	0.00277	CcSEcCtD
Gabapentin—Hepatobiliary disease—Temozolomide—malignant glioma	0.0017	0.00269	CcSEcCtD
Gabapentin—Sinusitis—Temozolomide—malignant glioma	0.00168	0.00267	CcSEcCtD
Gabapentin—BCAT1—Amino acid and derivative metabolism—SLC5A5—malignant glioma	0.00168	0.0152	CbGpPWpGaD
Gabapentin—Haemorrhage—Carmustine—malignant glioma	0.00167	0.00264	CcSEcCtD
Gabapentin—Hallucination—Carmustine—malignant glioma	0.00166	0.00263	CcSEcCtD
Gabapentin—Hypoaesthesia—Carmustine—malignant glioma	0.00166	0.00263	CcSEcCtD
Gabapentin—Oedema peripheral—Carmustine—malignant glioma	0.00164	0.00261	CcSEcCtD
Gabapentin—Connective tissue disorder—Carmustine—malignant glioma	0.00164	0.0026	CcSEcCtD
Gabapentin—Haemorrhage—Temozolomide—malignant glioma	0.00161	0.00256	CcSEcCtD
Gabapentin—Hepatitis—Temozolomide—malignant glioma	0.00161	0.00256	CcSEcCtD
Gabapentin—Visual impairment—Carmustine—malignant glioma	0.00161	0.00255	CcSEcCtD
Gabapentin—Hypoaesthesia—Temozolomide—malignant glioma	0.0016	0.00254	CcSEcCtD
Gabapentin—Hallucination—Temozolomide—malignant glioma	0.0016	0.00254	CcSEcCtD
Gabapentin—Pharyngitis—Temozolomide—malignant glioma	0.0016	0.00254	CcSEcCtD
Gabapentin—Urinary tract disorder—Temozolomide—malignant glioma	0.00159	0.00252	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—NTRK3—malignant glioma	0.00159	0.0144	CbGpPWpGaD
Gabapentin—Oedema peripheral—Temozolomide—malignant glioma	0.00159	0.00252	CcSEcCtD
Gabapentin—Connective tissue disorder—Temozolomide—malignant glioma	0.00158	0.00251	CcSEcCtD
Gabapentin—Urethral disorder—Temozolomide—malignant glioma	0.00158	0.00251	CcSEcCtD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—GJA1—malignant glioma	0.00158	0.0143	CbGpPWpGaD
Gabapentin—Eye disorder—Carmustine—malignant glioma	0.00156	0.00247	CcSEcCtD
Gabapentin—Visual impairment—Temozolomide—malignant glioma	0.00155	0.00246	CcSEcCtD
Gabapentin—Erythema multiforme—Temozolomide—malignant glioma	0.00152	0.00242	CcSEcCtD
Gabapentin—Eye disorder—Temozolomide—malignant glioma	0.0015	0.00239	CcSEcCtD
Gabapentin—Tinnitus—Temozolomide—malignant glioma	0.0015	0.00238	CcSEcCtD
Gabapentin—Cardiac disorder—Temozolomide—malignant glioma	0.00149	0.00237	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—BCHE—malignant glioma	0.00148	0.0134	CbGpPWpGaD
Gabapentin—Alopecia—Carmustine—malignant glioma	0.00147	0.00234	CcSEcCtD
Gabapentin—BCAT1—Metabolism—RTEL1—malignant glioma	0.00147	0.0133	CbGpPWpGaD
Gabapentin—Mental disorder—Carmustine—malignant glioma	0.00146	0.00232	CcSEcCtD
Gabapentin—Immune system disorder—Temozolomide—malignant glioma	0.00145	0.00231	CcSEcCtD
Gabapentin—Mediastinal disorder—Temozolomide—malignant glioma	0.00145	0.0023	CcSEcCtD
Gabapentin—Erythema—Carmustine—malignant glioma	0.00145	0.0023	CcSEcCtD
Gabapentin—Malnutrition—Carmustine—malignant glioma	0.00145	0.0023	CcSEcCtD
Gabapentin—Chills—Temozolomide—malignant glioma	0.00144	0.00229	CcSEcCtD
Gabapentin—Alopecia—Temozolomide—malignant glioma	0.00142	0.00226	CcSEcCtD
Gabapentin—Mental disorder—Temozolomide—malignant glioma	0.00141	0.00224	CcSEcCtD
Gabapentin—Back pain—Carmustine—malignant glioma	0.0014	0.00223	CcSEcCtD
Gabapentin—Malnutrition—Temozolomide—malignant glioma	0.0014	0.00222	CcSEcCtD
Gabapentin—Erythema—Temozolomide—malignant glioma	0.0014	0.00222	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.00139	0.0126	CbGpPWpGaD
Gabapentin—Dysgeusia—Temozolomide—malignant glioma	0.00137	0.00218	CcSEcCtD
Gabapentin—Vision blurred—Carmustine—malignant glioma	0.00137	0.00217	CcSEcCtD
Gabapentin—Tremor—Carmustine—malignant glioma	0.00136	0.00216	CcSEcCtD
Gabapentin—Back pain—Temozolomide—malignant glioma	0.00136	0.00215	CcSEcCtD
Gabapentin—Anaemia—Carmustine—malignant glioma	0.00134	0.00213	CcSEcCtD
Gabapentin—Agitation—Carmustine—malignant glioma	0.00133	0.00212	CcSEcCtD
Gabapentin—Vision blurred—Temozolomide—malignant glioma	0.00132	0.0021	CcSEcCtD
Gabapentin—Tremor—Temozolomide—malignant glioma	0.00131	0.00208	CcSEcCtD
Gabapentin—Ill-defined disorder—Temozolomide—malignant glioma	0.0013	0.00206	CcSEcCtD
Gabapentin—Leukopenia—Carmustine—malignant glioma	0.0013	0.00206	CcSEcCtD
Gabapentin—Anaemia—Temozolomide—malignant glioma	0.0013	0.00206	CcSEcCtD
Gabapentin—Agitation—Temozolomide—malignant glioma	0.00129	0.00204	CcSEcCtD
Gabapentin—Angioedema—Temozolomide—malignant glioma	0.00128	0.00203	CcSEcCtD
Gabapentin—Malaise—Temozolomide—malignant glioma	0.00126	0.00201	CcSEcCtD
Gabapentin—Vertigo—Temozolomide—malignant glioma	0.00126	0.002	CcSEcCtD
Gabapentin—Convulsion—Carmustine—malignant glioma	0.00126	0.00199	CcSEcCtD
Gabapentin—Leukopenia—Temozolomide—malignant glioma	0.00125	0.00199	CcSEcCtD
Gabapentin—Hypertension—Carmustine—malignant glioma	0.00125	0.00199	CcSEcCtD
Gabapentin—Palpitations—Temozolomide—malignant glioma	0.00124	0.00197	CcSEcCtD
Gabapentin—Chest pain—Carmustine—malignant glioma	0.00123	0.00196	CcSEcCtD
Gabapentin—Myalgia—Carmustine—malignant glioma	0.00123	0.00196	CcSEcCtD
Gabapentin—Anxiety—Carmustine—malignant glioma	0.00123	0.00195	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MMP9—malignant glioma	0.00123	0.0111	CbGpPWpGaD
Gabapentin—Cough—Temozolomide—malignant glioma	0.00122	0.00194	CcSEcCtD
Gabapentin—Convulsion—Temozolomide—malignant glioma	0.00121	0.00193	CcSEcCtD
Gabapentin—Hypertension—Temozolomide—malignant glioma	0.00121	0.00192	CcSEcCtD
Gabapentin—Confusional state—Carmustine—malignant glioma	0.00119	0.00189	CcSEcCtD
Gabapentin—Myalgia—Temozolomide—malignant glioma	0.00119	0.00189	CcSEcCtD
Gabapentin—Arthralgia—Temozolomide—malignant glioma	0.00119	0.00189	CcSEcCtD
Gabapentin—Anxiety—Temozolomide—malignant glioma	0.00119	0.00189	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00119	0.00188	CcSEcCtD
Gabapentin—Oedema—Carmustine—malignant glioma	0.00118	0.00188	CcSEcCtD
Gabapentin—Discomfort—Temozolomide—malignant glioma	0.00118	0.00187	CcSEcCtD
Gabapentin—Infection—Carmustine—malignant glioma	0.00118	0.00187	CcSEcCtD
Gabapentin—Dry mouth—Temozolomide—malignant glioma	0.00117	0.00185	CcSEcCtD
Gabapentin—Thrombocytopenia—Carmustine—malignant glioma	0.00116	0.00184	CcSEcCtD
Gabapentin—Tachycardia—Carmustine—malignant glioma	0.00116	0.00183	CcSEcCtD
Gabapentin—Confusional state—Temozolomide—malignant glioma	0.00115	0.00183	CcSEcCtD
Gabapentin—Oedema—Temozolomide—malignant glioma	0.00114	0.00182	CcSEcCtD
Gabapentin—Anaphylactic shock—Temozolomide—malignant glioma	0.00114	0.00182	CcSEcCtD
Gabapentin—Infection—Temozolomide—malignant glioma	0.00114	0.0018	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—BCHE—malignant glioma	0.00113	0.0102	CbGpPWpGaD
Gabapentin—Anorexia—Carmustine—malignant glioma	0.00113	0.00179	CcSEcCtD
Gabapentin—Nervous system disorder—Temozolomide—malignant glioma	0.00112	0.00178	CcSEcCtD
Gabapentin—Thrombocytopenia—Temozolomide—malignant glioma	0.00112	0.00178	CcSEcCtD
Gabapentin—Skin disorder—Temozolomide—malignant glioma	0.00111	0.00176	CcSEcCtD
Gabapentin—Hypotension—Carmustine—malignant glioma	0.00111	0.00176	CcSEcCtD
Gabapentin—Hyperhidrosis—Temozolomide—malignant glioma	0.00111	0.00176	CcSEcCtD
Gabapentin—Anorexia—Temozolomide—malignant glioma	0.00109	0.00173	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00108	0.00171	CcSEcCtD
Gabapentin—Insomnia—Carmustine—malignant glioma	0.00107	0.0017	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—SLC6A3—malignant glioma	0.00106	0.00963	CbGpPWpGaD
Gabapentin—Paraesthesia—Carmustine—malignant glioma	0.00106	0.00169	CcSEcCtD
Gabapentin—Dyspnoea—Carmustine—malignant glioma	0.00106	0.00167	CcSEcCtD
Gabapentin—Somnolence—Carmustine—malignant glioma	0.00105	0.00167	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00104	0.00165	CcSEcCtD
Gabapentin—Insomnia—Temozolomide—malignant glioma	0.00103	0.00164	CcSEcCtD
Gabapentin—Decreased appetite—Carmustine—malignant glioma	0.00103	0.00163	CcSEcCtD
Gabapentin—Paraesthesia—Temozolomide—malignant glioma	0.00103	0.00163	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00102	0.00162	CcSEcCtD
Gabapentin—Dyspnoea—Temozolomide—malignant glioma	0.00102	0.00162	CcSEcCtD
Gabapentin—Somnolence—Temozolomide—malignant glioma	0.00102	0.00161	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MYC—malignant glioma	0.00101	0.00918	CbGpPWpGaD
Gabapentin—Pain—Carmustine—malignant glioma	0.00101	0.00161	CcSEcCtD
Gabapentin—Constipation—Carmustine—malignant glioma	0.00101	0.00161	CcSEcCtD
Gabapentin—Dyspepsia—Temozolomide—malignant glioma	0.00101	0.0016	CcSEcCtD
Gabapentin—Decreased appetite—Temozolomide—malignant glioma	0.000994	0.00158	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000988	0.00157	CcSEcCtD
Gabapentin—Fatigue—Temozolomide—malignant glioma	0.000986	0.00157	CcSEcCtD
Gabapentin—Constipation—Temozolomide—malignant glioma	0.000978	0.00155	CcSEcCtD
Gabapentin—Pain—Temozolomide—malignant glioma	0.000978	0.00155	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000978	0.00885	CbGpPWpGaD
Gabapentin—Feeling abnormal—Carmustine—malignant glioma	0.000976	0.00155	CcSEcCtD
Gabapentin—Gastrointestinal pain—Carmustine—malignant glioma	0.000968	0.00154	CcSEcCtD
Gabapentin—Feeling abnormal—Temozolomide—malignant glioma	0.000943	0.0015	CcSEcCtD
Gabapentin—Body temperature increased—Carmustine—malignant glioma	0.000936	0.00149	CcSEcCtD
Gabapentin—Abdominal pain—Carmustine—malignant glioma	0.000936	0.00149	CcSEcCtD
Gabapentin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000935	0.00148	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.00092	0.00832	CbGpPWpGaD
Gabapentin—Urticaria—Temozolomide—malignant glioma	0.000909	0.00144	CcSEcCtD
Gabapentin—Abdominal pain—Temozolomide—malignant glioma	0.000904	0.00144	CcSEcCtD
Gabapentin—Body temperature increased—Temozolomide—malignant glioma	0.000904	0.00144	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—RTEL1—malignant glioma	0.000888	0.00804	CbGpPWpGaD
Gabapentin—Hypersensitivity—Carmustine—malignant glioma	0.000872	0.00138	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—CCR4—malignant glioma	0.000866	0.00784	CbGpPWpGaD
Gabapentin—Asthenia—Carmustine—malignant glioma	0.000849	0.00135	CcSEcCtD
Gabapentin—Hypersensitivity—Temozolomide—malignant glioma	0.000843	0.00134	CcSEcCtD
Gabapentin—BCAT1—Metabolism—COX8A—malignant glioma	0.000842	0.00762	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TP53—malignant glioma	0.000833	0.00754	CbGpPWpGaD
Gabapentin—Asthenia—Temozolomide—malignant glioma	0.000821	0.0013	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—PML—malignant glioma	0.000813	0.00736	CbGpPWpGaD
Gabapentin—Diarrhoea—Carmustine—malignant glioma	0.00081	0.00129	CcSEcCtD
Gabapentin—Pruritus—Temozolomide—malignant glioma	0.000809	0.00128	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	0.000804	0.00727	CbGpPWpGaD
Gabapentin—Dizziness—Carmustine—malignant glioma	0.000783	0.00124	CcSEcCtD
Gabapentin—Diarrhoea—Temozolomide—malignant glioma	0.000783	0.00124	CcSEcCtD
Gabapentin—Dizziness—Temozolomide—malignant glioma	0.000757	0.0012	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000754	0.00682	CbGpPWpGaD
Gabapentin—Vomiting—Carmustine—malignant glioma	0.000753	0.00119	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—BCHE—malignant glioma	0.000749	0.00678	CbGpPWpGaD
Gabapentin—Rash—Carmustine—malignant glioma	0.000746	0.00118	CcSEcCtD
Gabapentin—Dermatitis—Carmustine—malignant glioma	0.000746	0.00118	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—TOP2A—malignant glioma	0.000744	0.00673	CbGpPWpGaD
Gabapentin—Headache—Carmustine—malignant glioma	0.000742	0.00118	CcSEcCtD
Gabapentin—Vomiting—Temozolomide—malignant glioma	0.000727	0.00115	CcSEcCtD
Gabapentin—Rash—Temozolomide—malignant glioma	0.000721	0.00114	CcSEcCtD
Gabapentin—Dermatitis—Temozolomide—malignant glioma	0.000721	0.00114	CcSEcCtD
Gabapentin—Headache—Temozolomide—malignant glioma	0.000717	0.00114	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ASMT—malignant glioma	0.000716	0.00648	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—SLC6A3—malignant glioma	0.000705	0.00638	CbGpPWpGaD
Gabapentin—Nausea—Carmustine—malignant glioma	0.000703	0.00112	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.000689	0.00623	CbGpPWpGaD
Gabapentin—Nausea—Temozolomide—malignant glioma	0.00068	0.00108	CcSEcCtD
Gabapentin—BCAT1—Metabolism—BCAN—malignant glioma	0.000673	0.00609	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCR3—malignant glioma	0.000644	0.00583	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000631	0.00572	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000629	0.0057	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.000597	0.00541	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—BDKRB2—malignant glioma	0.000589	0.00533	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—NTRK1—malignant glioma	0.000578	0.00524	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—BRAF—malignant glioma	0.000577	0.00523	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.000546	0.00494	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—IDH2—malignant glioma	0.000542	0.00491	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—KNG1—malignant glioma	0.000536	0.00485	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCR4—malignant glioma	0.000524	0.00475	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.000512	0.00463	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—COX8A—malignant glioma	0.00051	0.00462	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP2B6—malignant glioma	0.00051	0.00462	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—NCOR1—malignant glioma	0.000506	0.00458	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000499	0.00452	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—MDM2—malignant glioma	0.000484	0.00438	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—RAF1—malignant glioma	0.000482	0.00436	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.000468	0.00424	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—IDH1—malignant glioma	0.000466	0.00422	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SPHK1—malignant glioma	0.000451	0.00409	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LATS2—malignant glioma	0.000448	0.00405	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP2C18—malignant glioma	0.000442	0.004	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ASMT—malignant glioma	0.000434	0.00392	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.000426	0.00385	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000418	0.00379	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000417	0.00377	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—BCAN—malignant glioma	0.000408	0.00369	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCR3—malignant glioma	0.00039	0.00353	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—BRAF—malignant glioma	0.000382	0.00346	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PPARG—malignant glioma	0.000362	0.00328	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTT1—malignant glioma	0.000358	0.00324	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—BDKRB2—malignant glioma	0.000356	0.00323	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LATS1—malignant glioma	0.000339	0.00307	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS1—malignant glioma	0.000335	0.00303	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—IDH2—malignant glioma	0.000329	0.00297	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—KNG1—malignant glioma	0.000324	0.00294	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—MDM2—malignant glioma	0.00032	0.0029	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—RAF1—malignant glioma	0.000319	0.00289	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—BCHE—malignant glioma	0.000311	0.00282	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP2B6—malignant glioma	0.000309	0.0028	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SLC5A5—malignant glioma	0.000308	0.00279	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCR4—malignant glioma	0.000296	0.00268	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—IDH1—malignant glioma	0.000283	0.00256	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000275	0.00249	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SPHK1—malignant glioma	0.000273	0.00247	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCR4—malignant glioma	0.000269	0.00244	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP2C18—malignant glioma	0.000268	0.00242	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PTEN—malignant glioma	0.000249	0.00225	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTP1—malignant glioma	0.000248	0.00224	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCL8—malignant glioma	0.000244	0.00221	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CAT—malignant glioma	0.000241	0.00218	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MDK—malignant glioma	0.000229	0.00208	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NCOR1—malignant glioma	0.000228	0.00206	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCR3—malignant glioma	0.00022	0.00199	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DTX1—malignant glioma	0.000219	0.00198	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTT1—malignant glioma	0.000217	0.00196	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—F2—malignant glioma	0.00021	0.0019	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS1—malignant glioma	0.000203	0.00184	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—BDKRB2—malignant glioma	0.000201	0.00182	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCR3—malignant glioma	0.0002	0.00181	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000194	0.00176	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—BCHE—malignant glioma	0.000189	0.00171	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC5A5—malignant glioma	0.000186	0.00169	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CAV1—malignant glioma	0.000186	0.00168	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—KNG1—malignant glioma	0.000183	0.00166	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—BDKRB2—malignant glioma	0.000183	0.00166	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SUFU—malignant glioma	0.000174	0.00157	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HEY2—malignant glioma	0.000172	0.00155	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—malignant glioma	0.00017	0.00154	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CG—malignant glioma	0.000169	0.00153	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GFAP—malignant glioma	0.000168	0.00152	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—KNG1—malignant glioma	0.000166	0.00151	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARG—malignant glioma	0.000163	0.00148	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SPHK1—malignant glioma	0.000162	0.00147	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HEY1—malignant glioma	0.000159	0.00144	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCR4—malignant glioma	0.000159	0.00144	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIST1H3B—malignant glioma	0.000154	0.0014	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTP1—malignant glioma	0.00015	0.00136	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CD—malignant glioma	0.000149	0.00135	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCL8—malignant glioma	0.000148	0.00134	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MMP3—malignant glioma	0.000147	0.00133	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CAT—malignant glioma	0.000146	0.00132	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JAG2—malignant glioma	0.000141	0.00128	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOR1—malignant glioma	0.000138	0.00125	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CB—malignant glioma	0.00013	0.00117	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS2—malignant glioma	0.000128	0.00116	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—H3F3A—malignant glioma	0.000119	0.00108	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—F2—malignant glioma	0.000118	0.00107	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCR3—malignant glioma	0.000118	0.00107	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—YWHAE—malignant glioma	0.000115	0.00104	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NTRK2—malignant glioma	0.000115	0.00104	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FLT1—malignant glioma	0.000114	0.00104	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DUSP6—malignant glioma	0.000114	0.00103	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000113	0.00103	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CAV1—malignant glioma	0.000112	0.00102	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JAG1—malignant glioma	0.000112	0.00102	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOTCH3—malignant glioma	0.000112	0.00101	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTEN—malignant glioma	0.000112	0.00101	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FBXW7—malignant glioma	0.00011	0.000997	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BDKRB2—malignant glioma	0.000108	0.000978	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—F2—malignant glioma	0.000108	0.000974	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT2—malignant glioma	0.000104	0.000939	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CG—malignant glioma	0.000103	0.000932	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CG—malignant glioma	0.000102	0.000928	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PTPN11—malignant glioma	0.000101	0.000915	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOTCH2—malignant glioma	0.0001	0.000909	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CD—malignant glioma	9.96e-05	0.000902	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARG—malignant glioma	9.89e-05	0.000895	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KNG1—malignant glioma	9.83e-05	0.00089	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT2—malignant glioma	9.42e-05	0.000852	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NTRK1—malignant glioma	9.37e-05	0.000848	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CD—malignant glioma	9.05e-05	0.000819	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CD—malignant glioma	9.01e-05	0.000815	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP3—malignant glioma	8.71e-05	0.000788	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CB—malignant glioma	8.68e-05	0.000786	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN2B—malignant glioma	8.63e-05	0.000781	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTK2—malignant glioma	8.38e-05	0.000759	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL8—malignant glioma	8.35e-05	0.000755	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HES1—malignant glioma	8.24e-05	0.000745	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NCOR1—malignant glioma	8.19e-05	0.000741	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RAF1—malignant glioma	8.08e-05	0.000731	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IL2—malignant glioma	7.98e-05	0.000722	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CA—malignant glioma	7.9e-05	0.000715	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CB—malignant glioma	7.89e-05	0.000714	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CB—malignant glioma	7.85e-05	0.000711	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDGFRA—malignant glioma	7.84e-05	0.00071	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS2—malignant glioma	7.78e-05	0.000704	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SPP1—malignant glioma	7.61e-05	0.000689	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL8—malignant glioma	7.58e-05	0.000686	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL2—malignant glioma	7.24e-05	0.000656	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TERT—malignant glioma	7.22e-05	0.000653	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDGFB—malignant glioma	7.04e-05	0.000638	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGFR1—malignant glioma	7.01e-05	0.000634	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIF1A—malignant glioma	6.9e-05	0.000625	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTEN—malignant glioma	6.78e-05	0.000614	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CAV1—malignant glioma	6.67e-05	0.000604	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KDR—malignant glioma	6.6e-05	0.000597	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—malignant glioma	6.45e-05	0.000584	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FN1—malignant glioma	6.35e-05	0.000575	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—F2—malignant glioma	6.35e-05	0.000575	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BAD—malignant glioma	6.28e-05	0.000568	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOTCH1—malignant glioma	6.22e-05	0.000563	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CD80—malignant glioma	6.09e-05	0.000551	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APC—malignant glioma	6.08e-05	0.00055	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CG—malignant glioma	6.08e-05	0.00055	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGF—malignant glioma	6.01e-05	0.000544	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTPN11—malignant glioma	5.97e-05	0.000541	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BRAF—malignant glioma	5.71e-05	0.000517	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT2—malignant glioma	5.56e-05	0.000504	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EGFR—malignant glioma	5.54e-05	0.000501	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CD—malignant glioma	5.34e-05	0.000484	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CA—malignant glioma	5.29e-05	0.000479	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—KRAS—malignant glioma	5.23e-05	0.000474	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGF2—malignant glioma	5.12e-05	0.000463	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CA—malignant glioma	4.81e-05	0.000435	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MDM2—malignant glioma	4.79e-05	0.000433	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CA—malignant glioma	4.79e-05	0.000433	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RAF1—malignant glioma	4.77e-05	0.000432	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ERBB2—malignant glioma	4.72e-05	0.000427	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CB—malignant glioma	4.66e-05	0.000422	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL8—malignant glioma	4.48e-05	0.000405	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—malignant glioma	4.32e-05	0.000391	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—malignant glioma	4.29e-05	0.000388	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL2—malignant glioma	4.28e-05	0.000387	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—malignant glioma	4.05e-05	0.000367	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTEN—malignant glioma	4.03e-05	0.000364	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—malignant glioma	3.93e-05	0.000356	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—malignant glioma	3.91e-05	0.000354	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—malignant glioma	3.64e-05	0.000329	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT3—malignant glioma	3.6e-05	0.000326	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYC—malignant glioma	3.35e-05	0.000303	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGFR—malignant glioma	3.27e-05	0.000296	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KRAS—malignant glioma	3.09e-05	0.00028	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CA—malignant glioma	2.84e-05	0.000257	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—malignant glioma	2.75e-05	0.000249	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—malignant glioma	2.32e-05	0.00021	CbGpPWpGaD
